Relevance of Pro-BNB Biomarker with Left Ventricular Ejection Fraction in Coronary Artery Disease (CAD) Patients
Ola Muslim Alhussainy, Dr. Haider Abd Jabbar ALammar,
Dr. Aqeel Raheem Al-Barqawee
The relationship between newly discovered biomarkers Regarding the fraction of left ventricle ejection in individuals suffering from coronary artery disease (CAD).Coronary artery disease is one of the major non-communicable diseases in the world. Coronary artery damage can be caused by a number of important risk factors, such as smoking, diabetes mellitus, dyslipidemia, and hypertension (1). When compared to other plasma neurohormones, B-type natriuretic peptide (BNP) and its amino-terminal congeners differ. Studies reveal that, compared to symptomatic examination, changes in plasma BNP levels during treatment for acutely decompensated heart failure offer a more potent predictive indication of the chance of survival or recurrent decompensation.(1). This observation necessitates a randomized controlled study where aggression is determined by alterations in peptide levels. The length of in-patient treatment to determine if this indicator can enhance the outcomes of acute in-patient heart failure management. When following up on heart failure cohorts over an extended period of time, plasma BNP or NT-proBNP is a highly effective independent predictor of death and morbidity. Furthermore, it seems to be a reliable indicator of a positive reaction when beta blocker is added to anti-heart failure medication. When changing therapy for heart failure based on serial measures of NT-proBNP, as opposed to altering therapy based on independent clinical judgment, better results are expectedResearching of new biomarkers such as B-type natriuretic peptide (BNP). Associated Patients suffering from coronary artery disease (CAD) with left ventricular ejection fraction. B-type natriuretic peptide (BNP) levels in the serum were determined using the ELISA technique. Associated using the left ventricular ejection fraction when suffering from coronary heart disease)CAD Patients. Serum urea, creatinine, and RBS are measured using colorimetric and fully automated methods. Between individuals with coronary artery disease )CAD Patients and the healthy group, Pro-BNP, serum creatinine, urea, and RBS all differ statistically significantly. Individuals with coronary artery disease had significantly greater amounts of Pro-BNP and, which are diagnostic markers.
Keywords: B-type natriuretic peptide (BNP), Coronary artery disease (CAD), ELISA
